Sargent Bickham Lagudis’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Sargent Bickham Lagudis’s Portfolio TMDI Stock Details TMDI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$20	Hold	30	–	–	﹤0.01%	1048
2022 Q3	$0	Hold	30	–	–	﹤0.01%	1162
2022 Q2	$0	Hold	30	–	–	﹤0.01%	1166
2022 Q1	$0	Hold	30	–	–	﹤0.01%	1045
2021 Q4	$0	Hold	30	–	–	﹤0.01%	1040
2021 Q3	$0	Hold	30	–	–	﹤0.01%	1014
2021 Q2	$0	Hold	30	–	–	﹤0.01%	1024
2021 Q1	$0	Hold	30	–	–	﹤0.01%	1002
2020 Q4	$0	Hold	30	–	–	﹤0.01%	930
2020 Q3	$0	Hold	30	–	–	﹤0.01%	848
2020 Q2	$0	Hold	30	–	–	﹤0.01%	837
2020 Q1	$0	Buy	+30	New	+$12	﹤0.01%	947
2019 Q3	–	Sell	-63	Closed	–	–	799
2019 Q2	$0	Hold	63	–	–	﹤0.01%	824
2019 Q1	$0	Hold	63	–	–	﹤0.01%	850
2018 Q4	$0	Hold	63	–	–	﹤0.01%	812
2018 Q3	$0	Hold	63	–	–	﹤0.01%	798
2018 Q2	$0	Buy	+63	New	+$379	﹤0.01%	812

Other funds holding TMDI

Essex LLC Deer Park, Illinois $659M AUM 41.98% 1-Year Est. Return

AlphaQ Advisors Winter Park, Florida $41.7M AUM 12.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.7B AUM 31.52% 1-Year Est. Return

SAG

SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Waterford Advisors Orchard Park, New York $315M AUM 15.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Sargent Bickham Lagudis's TMDI Position: Q4 2022 in Review

Sargent Bickham Lagudis held its Titan Medical Inc. Ordinary Shares (TMDI) position steady in Q4 2022 at 30 shares worth $20. The position accounts for ﹤0.01% of the portfolio, ranked #1048.

Sargent Bickham Lagudis first reported a position in TMDI in Q2 2018 and has held it in 17 quarters since. 71 funds tracked by Wall St. Rank hold TMDI as of Q4 2022.

Sargent Bickham Lagudis held 30 shares of Titan Medical Inc. Ordinary Shares worth $20 as of Q4 2022.
Sargent Bickham Lagudis left its Titan Medical Inc. Ordinary Shares share count unchanged in Q4 2022.
Titan Medical Inc. Ordinary Shares made up ﹤0.01% of Sargent Bickham Lagudis's portfolio in Q4 2022, its #1048 holding.
Sargent Bickham Lagudis first reported a position in Titan Medical Inc. Ordinary Shares in Q2 2018 and has held it in 17 quarters since.
71 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q4 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2022, filed 23 Jan 2023.